Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSC-Exos Therapy for Type 2 Diabetes
NCT07144241Phase 2Not yet recruiting
- Sponsor
- Universitas Indonesia
- Start
- Sep 2025
- Primary completion
- Dec 2025
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 2 trial of Exo-HWS in type 2 diabetes mellitus (T2DM), sponsored by Universitas Indonesia. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
Exo-HWS
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07144241.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07144241.